Suppr超能文献

大环环尺寸对含吡啶螯合剂中 [Pb]Pb(II) 配合物稳定性影响的评价。

Evaluation of the Effect of Macrocyclic Ring Size on [Pb]Pb(II) Complex Stability in Pyridyl-Containing Chelators.

机构信息

Department of Chemistry, Simon Fraser University, Burnaby, British Columbia V5A 1S6, Canada.

Life Sciences Division, TRIUMF, Vancouver, British Columbia V6T 2A3, Canada.

出版信息

Inorg Chem. 2022 Jun 27;61(25):9638-9649. doi: 10.1021/acs.inorgchem.2c01114. Epub 2022 Jun 15.

Abstract

As an element-equivalent theranostic pair, lead-203 (Pb, 100% EC, half-life = 51.92 h) and lead-212 (Pb, 100% β, half-life = 10.64 h), through the emission of γ rays and an α particle in its decay chain, respectively, can aid in the development of personalized targeted radionuclide treatment for advanced and currently untreatable cancers. With these isotopes currently being used in clinical trials, an understanding of the relationship between the chelator structure, ability to incorporate the radiometal, and metal-complex stability is needed to help design appropriate chelators for clinical use. Herein, we report an investigation into the effect of ring size in macrocyclic chelators where pyridine, an intermediate Lewis base, acts as an electron donor toward lead. Crown-4Py (4,7,13,16-tetrakis(pyridin-2-ylmethyl)-1,10-dioxa-4,7,13,16-tetraazacyclooctadecane), cyclen-4Py (1,4,7,10-tetrakis(pyridin-2-ylmethyl)-1,4,7,10-tetraazacyclododecane), and NOON-2Py (7,16-bis(pyridin-2-ylmethyl)-1,4,10,13-tetraoxa-7,16-diazacyclooctadecane) were synthesized and analyzed for their ability to coordinate Pb. Metal complex stability was investigated via [Pb]Pb radiolabeling studies, H NMR spectroscopy, X-ray crystallography, and potentiometry. With the smallest macrocyclic backbone, cyclen-4Py had the highest radiochemical yield, while, in descending order, crown-4Py and NOON-2Py had the lowest. Thermodynamic stability constants (log ) of 19.95(3), 13.29(5), and 11.67 for [Pb(Cyclen-4Py)], [Pb(Crown-4Py)], and [Pb(NOON-2Py)], respectively, correlated with their radiochemical yields. The X-ray crystal structure of the least stable complexes [Pb(NOON-2Py)] revealed a hemidirected Pb center, as reflected by a void within the coordination sphere, and [Pb(Crown-4Py)] showed an average Pb-N pyridine interatomic distance of >3 Å. By contrast, the crystal structure of [Pb(Cyclen-4Py)] showed shorter Pb-N pyridine interactions, and in solution, only one highly symmetric isomer existed for this complex, whereas conformational flexibility was observed for both [Pb(Crown-4Py)] and [Pb(NOON-2Py)] at the NMR timescale. This study illustrates the importance of the macrocyclic backbone size when incorporating bulky electron-donor groups into the design of a macrocyclic chelator as it affects the accessibility of lead to the donor arms. Our results show that cyclen-4Py is a promising chelator for future studies with this theranostic pair.

摘要

作为一种元素等效的治疗诊断双模态系统,铅-203(Pb,100% EC,半衰期=51.92 h)和铅-212(Pb,100%β,半衰期=10.64 h),分别通过其衰变链中γ射线和α粒子的发射,可辅助开发针对晚期和目前无法治疗的癌症的个性化靶向放射性核素治疗。随着这些同位素目前正在临床试验中使用,需要了解螯合剂结构、掺入放射性金属的能力以及金属配合物稳定性之间的关系,以帮助设计用于临床使用的适当螯合剂。在此,我们报告了在大环螯合剂中研究环大小的影响,其中吡啶是一种中间路易斯碱,可作为铅的电子供体。冠-4Py(4,7,13,16-四(吡啶-2-基甲基)-1,10-二氧杂-4,7,13,16-四氮杂环十八烷)、环烯-4Py(1,4,7,10-四(吡啶-2-基甲基)-1,4,7,10-四氮杂环十二烷)和 NOON-2Py(7,16-双(吡啶-2-基甲基)-1,4,10,13-四氧杂-7,16-二氮杂环十八烷)被合成并分析其与 Pb 的配位能力。通过[Pb]Pb 放射性标记研究、1H NMR 光谱、X 射线晶体学和电位法研究了金属配合物的稳定性。具有最小大环骨架的环烯-4Py 具有最高的放射化学产率,而冠-4Py 和 NOON-2Py 的放射化学产率则依次降低。热力学稳定常数(log)分别为 19.95(3)、13.29(5)和 11.67,分别为[Pb(Cyclen-4Py)]、[Pb(Crown-4Py)]和[Pb(NOON-2Py)]。X 射线晶体结构表明,最不稳定的配合物[Pb(NOON-2Py)]中 Pb 中心呈半指向性,反映在配位球内有空隙,而[Pb(Crown-4Py)]则显示 Pb-N 吡啶的平均原子间距离>3 Å。相比之下,[Pb(Cyclen-4Py)]的 X 射线晶体结构显示出较短的 Pb-N 吡啶相互作用,并且在溶液中,该配合物仅存在一种高度对称的异构体,而[Pb(Crown-4Py)]和[Pb(NOON-2Py)]在 NMR 时间尺度上表现出构象灵活性。这项研究说明了在设计大环螯合剂时将大体积供电子基团纳入设计时大环骨架大小的重要性,因为它会影响铅与供体臂的可及性。我们的结果表明,环烯-4Py 是该治疗诊断双模态系统未来研究的有前途的螯合剂。

相似文献

1
Evaluation of the Effect of Macrocyclic Ring Size on [Pb]Pb(II) Complex Stability in Pyridyl-Containing Chelators.
Inorg Chem. 2022 Jun 27;61(25):9638-9649. doi: 10.1021/acs.inorgchem.2c01114. Epub 2022 Jun 15.
2
Capturing Mercury-197m/g for Auger Electron Therapy and Cancer Theranostic with Sulfur-Containing Cyclen-Based Macrocycles.
Inorg Chem. 2024 Jul 29;63(30):14241-14255. doi: 10.1021/acs.inorgchem.4c02418. Epub 2024 Jul 18.
3
Tuning the Softness of the Pendant Arms and the Polyazamacrocyclic Backbone to Chelate the Pb/Pb Theranostic Pair.
Inorg Chem. 2024 Jan 29;63(4):1745-1758. doi: 10.1021/acs.inorgchem.3c02610. Epub 2024 Jan 17.
7
Getting a lead on Pb-amide chelators for Pb radiopharmaceuticals.
Dalton Trans. 2021 Sep 7;50(33):11579-11595. doi: 10.1039/d1dt01653a. Epub 2021 Aug 5.
8
Production, purification, and radiolabeling of the Pb/Pb theranostic pair.
EJNMMI Radiopharm Chem. 2021 Feb 1;6(1):6. doi: 10.1186/s41181-021-00121-4.

引用本文的文献

1
Pb in targeted radionuclide therapy: a review.
EJNMMI Radiopharm Chem. 2025 Jul 1;10(1):34. doi: 10.1186/s41181-025-00362-7.
2
3
Theoretical Study of Metal-Ligand Interactions in Lead Complexes with Radiopharmaceutical Interest.
Molecules. 2024 Sep 4;29(17):4198. doi: 10.3390/molecules29174198.
4
Chelation of [In]In with the dual-size-selective macrocycles py-macrodipa and py-macrodipa.
Dalton Trans. 2024 Sep 10;53(35):14634-14647. doi: 10.1039/d4dt02146k.
5
The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality?
EJNMMI Radiopharm Chem. 2023 Aug 3;8(1):17. doi: 10.1186/s41181-023-00202-6.
6
Diagnostic and Therapeutic Radiopharmaceuticals.
ACS Pharmacol Transl Sci. 2022 Sep 19;5(10):835-837. doi: 10.1021/acsptsci.2c00173. eCollection 2022 Oct 14.

本文引用的文献

3
Implications of physics, chemistry and biology for dosimetry calculations using theranostic pairs.
Theranostics. 2022 Jan 1;12(1):232-259. doi: 10.7150/thno.62851. eCollection 2022.
4
Getting a lead on Pb-amide chelators for Pb radiopharmaceuticals.
Dalton Trans. 2021 Sep 7;50(33):11579-11595. doi: 10.1039/d1dt01653a. Epub 2021 Aug 5.
6
Production, purification, and radiolabeling of the Pb/Pb theranostic pair.
EJNMMI Radiopharm Chem. 2021 Feb 1;6(1):6. doi: 10.1186/s41181-021-00121-4.
7
Synthesis and Evaluation of a Macrocyclic Actinium-225 Chelator, Quality Control and In Vivo Evaluation of Ac-crown-αMSH Peptide.
Chemistry. 2020 Sep 4;26(50):11435-11440. doi: 10.1002/chem.202002999. Epub 2020 Aug 28.
8
Theranostic radiopharmaceuticals: established agents in current use.
Br J Radiol. 2018 Nov;91(1091):20170969. doi: 10.1259/bjr.20170969. Epub 2018 Mar 12.
10
Targeted Radionuclide Therapy: Practical Applications and Future Prospects.
Biomark Cancer. 2016 May 18;8(Suppl 2):35-8. doi: 10.4137/BIC.S31804. eCollection 2016.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验